Doctors Without Borders calls on J&J to withdraw extended pa

Doctors Without Borders calls on J&J to withdraw extended patents on TB drug

AS Johnson & Johnson's (J&J) 20-year primary patent on the critical, lifesaving drug-resistant tuberculosis (DR-TB) drug bedaquiline expires in majority of countries, including India, Doctors Without Borders/Médecins Sans Frontières (MSF) reiterated its call for the US pharmaceutical corporation to publicly announce it will not enforce any 'secondary' patents for the drug in any country with a high burden of TB and withdraw and abandon all pending secondary patent applications for this critical drug everywhere.

Related Keywords

Barangay , Pangasinan , Philippines , Manila , New York , United States , India , Johnson , Trisha Thadhani , World Health Organization , Terms Of Service , Doctors Without Borders , Doctors Without , Sans Fronti , Tondo Districts , Without Borders , Manila Times , Doctors , Without , Borders , Calls , Son , J , To , Withdraw , Extended , Patents , Tb , Drug ,

© 2025 Vimarsana